Capecitabine, Trastuzumab, and Tucatinib

About

Membership operator: AND

Therapies: 3

Therapies

Capecitabine (tx:ncit:C1794)

Trastuzumab (tx:ncit:C1647)

Tucatinib (tx:ncit:C77896)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
EMA (1) FDA (2) HER2-positive Invasive Breast Carcinoma Capecitabine, Trastuzumab, Tucatinib